Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 1,417 | 1,203 | 3,095 | 434 | 1,502 |
| Gross Profit | 1,417 | 1,203 | 3,095 | 434 | 1,502 |
| Operating Expenses | 44,281 | 43,384 | 42,407 | 38,323 | 39,015 |
| Operating Income | -42,864 | -42,181 | -39,312 | -37,889 | -37,513 |
| Other Income | 4,215 | -12 | 320 | 424 | 952 |
| Pre-tax Income | -38,649 | -42,193 | -38,992 | -37,465 | -36,561 |
| Income Tax | 209 | 208 | 76 | 298 | 52 |
| Net Income Continuous | -38,858 | -42,401 | -39,068 | -37,763 | -36,613 |
| Net Income | $-38,858 | $-42,401 | $-39,068 | $-37,763 | $-36,613 |
| EPS Basic Total Ops | -0.27 | -0.27 | -0.24 | -0.24 | -0.21 |
| EPS Basic Continuous Ops | -0.25 | -0.27 | -0.25 | -0.24 | -0.24 |
| EPS Diluted Total Ops | -0.27 | -0.27 | -0.24 | -0.24 | -0.21 |
| EPS Diluted Continuous Ops | -0.25 | -0.27 | -0.25 | -0.24 | -0.24 |
| EBITDA(a) | $-40,630 | $-40,727 | $-37,869 | $-36,453 | $-37,868 |